Services

/ Strategic Advisory Projects /

/ Litigation Support /

/ Speeches and Executive Briefings /

Representative Projects

We provide strategic advisory services to a diverse mix of clients, including pharmaceutical manufacturers, pharmacy benefit managers, supply chain technology companies, law firms, health care providers, trade associations, and institutional investors. Dr. Adam J. Fein is fully involved in all assignments.

Here are a few recent topics for which clients have engaged us: 

• Market developments in relationships between pharmaceutical manufacturers and wholesalers.

• Options for managing the order-to-cash activities during the launch phase of an innovative new pharmaceutical product.

• Industry impact of pharmaceutical wholesaler fee-for-service agreements with manufacturers.

• Contractual terms in pharmaceutical wholesaler fee-for-service agreements with manufacturers.

• Supply chain improvement opportunities in the pharmaceutical wholesale channel.

• Business and financial overview of pharmaceutical wholesalers.

• The future of the retail pharmacy industry.

Dr. Fein personally advises institutional investors on pharmaceutical industry issues through an exclusive affiliation with Gerson Lehrman Group (GLG).  GLG clients can request a consultation with Dr. Fein via his GLG web page.